Forms of cholangitis to be considered after SARS-CoV-2 infection.
作者信息
Cho Ju-Yeon, Lee Young-Sun, Kim Soon Sun, Song Do Seon, Lee Jeong-Hoon, Kim Ji Hoon
机构信息
Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea.
Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2022 Oct;28(4):929-930. doi: 10.3350/cmh.2022.0260. Epub 2022 Sep 8.
Abstract
摘要
相似文献
1
Forms of cholangitis to be considered after SARS-CoV-2 infection.新型冠状病毒感染后需考虑的胆管炎形式。
Clin Mol Hepatol. 2022 Oct;28(4):929-930. doi: 10.3350/cmh.2022.0260. Epub 2022 Sep 8.
2
Temporal trend of mortality in patients with cirrhosis with primary biliary cholangitis and primary sclerosing cholangitis during the COVID-19 pandemic.新冠疫情期间原发性胆汁性胆管炎和原发性硬化性胆管炎所致肝硬化患者的死亡率随时间变化趋势
Gut. 2024 Jun 6;73(7):1217-1219. doi: 10.1136/gutjnl-2023-330271.
3
SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.SARS-CoV-2 疫苗接种在自身免疫性肝炎和自身免疫性胆汁淤积性肝病患者中的反应。
United European Gastroenterol J. 2022 Apr;10(3):319-329. doi: 10.1002/ueg2.12218. Epub 2022 Mar 15.
4
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study.新型冠状病毒感染后表现为原发性胆汁性胆管炎的自身免疫性肝病：基于人群的队列研究的必要性。
Clin Mol Hepatol. 2022 Oct;28(4):926-928. doi: 10.3350/cmh.2022.0233. Epub 2022 Sep 5.
5
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.一名原发性胆汁性胆管炎患者接种新型冠状病毒疫苗后发生亚急性皮肤型红斑狼疮。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e179-e180. doi: 10.1111/jdv.17827. Epub 2021 Dec 2.
6
Sclerosing cholangitis and primary biliary cirrhosis--a disease spectrum?硬化性胆管炎与原发性胆汁性肝硬化——一种疾病谱系？
Ann Surg. 1977 Nov;186(5):589-93. doi: 10.1097/00000658-197711000-00008.
7
Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.原发性胆汁性肝硬化、原发性硬化性胆管炎和自身免疫性胆管炎。
Clin Liver Dis. 2000 Feb;4(1):97-113. doi: 10.1016/s1089-3261(05)70098-2.
8
Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination.免疫介导的肝损伤表现为新型冠状病毒2型疫苗接种后的重叠综合征。
J Hepatol. 2022 Oct;77(4):1209-1211. doi: 10.1016/j.jhep.2022.06.029. Epub 2022 Jul 8.
9
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎中的胰腺
Gastroenterology. 1982 Dec;83(6):1177-82.
10
Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的识别
Am Fam Physician. 1996 Jan;53(1):195-200.
引用本文的文献
1
Post-COVID-19 cholangiopathy: Systematic review.新冠病毒感染后胆管病：系统评价
World J Methodol. 2023 Sep 20;13(4):296-322. doi: 10.5662/wjm.v13.i4.296.
2
Correspondence on Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis".关于“慢性肝病患者和肝移植受者中 COVID-19 疫苗免疫原性：一项荟萃分析”的信件往来
Clin Mol Hepatol. 2023 Jan;29(1):176-178. doi: 10.3350/cmh.2022.0377. Epub 2022 Nov 10.
本文引用的文献
1
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study.新型冠状病毒感染后表现为原发性胆汁性胆管炎的自身免疫性肝病：基于人群的队列研究的必要性。
Clin Mol Hepatol. 2022 Oct;28(4):926-928. doi: 10.3350/cmh.2022.0233. Epub 2022 Sep 5.
2
Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination.免疫介导的肝损伤表现为新型冠状病毒2型疫苗接种后的重叠综合征。
J Hepatol. 2022 Oct;77(4):1209-1211. doi: 10.1016/j.jhep.2022.06.029. Epub 2022 Jul 8.
3
Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study.COVID-19 后发性继发性硬化性胆管炎：一项多中心回顾性研究。
Clin Infect Dis. 2023 Feb 8;76(3):e179-e187. doi: 10.1093/cid/ciac565.
4
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline.2019年冠状病毒病（COVID-19）大流行期间肝病管理的最新情况：2021年KASL指南
Clin Mol Hepatol. 2021 Oct;27(4):515-523. doi: 10.3350/cmh.2021.0293. Epub 2021 Sep 17.
5
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.严重 COVID-19 后的胆管病：临床特征和预后意义。
Am J Gastroenterol. 2021 Jul 1;116(7):1414-1425. doi: 10.14309/ajg.0000000000001264.
6
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.新冠病毒感染后胆管病——肝移植的新适应证：病例报告。
Transplant Proc. 2021 May;53(4):1132-1137. doi: 10.1016/j.transproceed.2021.03.007. Epub 2021 Mar 12.
7
Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome Triggered by COVID-19.由新型冠状病毒肺炎引发的自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征
Eur J Case Rep Intern Med. 2021 Feb 4;8(3):002264. doi: 10.12890/2021_002264. eCollection 2021.
8
Primary biliary cholangitis associated with SARS-CoV-2 infection.与新型冠状病毒2型感染相关的原发性胆汁性胆管炎
J Hepatol. 2021 May;74(5):1245-1246. doi: 10.1016/j.jhep.2021.02.006. Epub 2021 Feb 19.
9
Pathophysiological mechanisms of liver injury in COVID-19.COVID-19 相关肝损伤的病理生理机制。
Liver Int. 2021 Jan;41(1):20-32. doi: 10.1111/liv.14730. Epub 2020 Nov 29.
10
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.2019 年冠状病毒病合并肝脏疾病患者的临床结局：韩国多中心研究。
Clin Mol Hepatol. 2020 Oct;26(4):562-576. doi: 10.3350/cmh.2020.0126. Epub 2020 Oct 1.
Zotero 插件